Register to view our free webinar about a one-day, hands-off NGS solution for any lab
While next-generation sequencing (NGS) has been instrumental to precision oncology research progress, practical hurdles have hindered its broad implementation. Until now.
We've just introduced the Ion Torrent Genexus System, the first fully integrated NGS platform featuring an automated specimen-to-report workflow* that delivers results economically in a single day.
In combination with the new Oncomine Precision Assay, the Genexus System represents a new-generation solution for genomic profiling and sets the stage for molecular pathology labs in the future to perform genomic profiling with the speed and simplicity of traditional testing modalities like immunohistochemistry.
View this exciting webinar to hear:
- How the all-new Ion Torrent Genexus System is addressing key challenges to NGS implementation like hands-on time, time-to-result, user expertise, and affordability
- Why, in combination with the new Oncomine Precision Assay, the Genexus System represents a new-generation solution for genomic profiling of cancer samples
- Thoughts from the first-ever laboratory to implement this solution - IPATIMUB in Portugal
José Luis Costa, PhD
Principal Researcher,
IPATIMUP
Porto, Portugal
View biography ›
Andy Felton
Vice President of Marketing and Product Management, Clinical Next Generation Sequencing
Thermo Fisher Scientific
View biography ›
Fill in the form to view the free on-demand webinar.
For Research Use Only. Not for use in diagnostic procedures. *Specimen-to-report workflow will be available after the Ion Torrent Genexus Purification System and integrated reporting capabilities are added in 2020.